<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGen</journal-id><journal-title-group><journal-title>Open Journal of Genetics</journal-title></journal-title-group><issn pub-type="epub">2162-4453</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgen.2020.103005</article-id><article-id pub-id-type="publisher-id">OJGen-104640</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  &lt;i&gt;GJB2&lt;/i&gt; Gene Related Nonsyndromic Hearing Loss in Mazandaran Province, North of Iran
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Elaheh</surname><given-names>Hosseini</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Seyed</surname><given-names>Saeid Mousavi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Atefeh</surname><given-names>Khoshaein</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fatemeh</surname><given-names>Daneshpour</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moosa</surname><given-names>Rajabi Vandchali</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>S.</surname><given-names>Mohammad Bagher Hashemi-Soteh</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Mehregan Genetic Counseling Center, Sari, Iran</addr-line></aff><aff id="aff1"><addr-line>Novin Genetic Diagnostic Laboratory, Sari, Iran</addr-line></aff><aff id="aff5"><addr-line>Immunogenetic Research Center, Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</addr-line></aff><aff id="aff4"><addr-line>Genetic Counseling Center, State Welfare Organization of Mazandaran Province, Sari, Iran</addr-line></aff><aff id="aff3"><addr-line>Novin Genetic Counseling Center, Sari, Iran</addr-line></aff><pub-date pub-type="epub"><day>30</day><month>09</month><year>2020</year></pub-date><volume>10</volume><issue>03</issue><fpage>51</fpage><lpage>63</lpage><history><date date-type="received"><day>13,</day>	<month>August</month>	<year>2020</year></date><date date-type="rev-recd"><day>27,</day>	<month>September</month>	<year>2020</year>	</date><date date-type="accepted"><day>30,</day>	<month>September</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Congenital hearing loss is the most common sensory deficit in the world and mutations in 
  <em>GJB2</em> gene are the most common cause of deafness in many populations. Frequency of 
  <em>GJB2</em> mutations is estimated about 16% in Iran and varies among different provinces with a decreasing trend from north to south. The aim of this study was to investigate the frequency of 
  <em>GJB2</em> mutations in Mazandaran province, north of Iran, among non-syndromic hearing loss patients. 
  Methods: 262 patients from 204 families participated in this study. After genomic DNA extraction, 
  <em>GJB2</em> gene analysis was carried out using DNA sequencing of both coding and non-coding regions by ABI 3130XL genetic analyzer. 
  Results: 30.15% of all subjects showed mutations in GJB2 gene. Four mutations, including c.35delG (Gly12Valfs*), IVSI-1 + 1G &gt; A, c.95G &gt; A (Arg32His) and c.224 G &gt; A (Arg75Gln) comprises 69.89% of all mutations in this study c.35delG and IVSI-1 were the most common mutations among patients respectively. Codon 75 mutation (c.224G &gt; A. p: Arg75Gln) with autosomal dominant inheritance was seen in 7 cases from 3 families. 22 patients showed only one mutation in 
  <em>GJB2</em> gene and in 126 (48.09%) individuals, parents had a consanguineous marriage. 
  Discussion: Frequency of 
  <em>GJB2</em> gene related hearing loss among patients was higher than average (16%) in this province. This study also showed a dominant inheritance pattern of 
  <em>GJB2</em> gene in this area. Consanguineous marriage also showed highly frequent among parents. More investigation needs to clarify cause of hearing loss in those 22 patients with one mutation in 
  <em>GJB2</em> gene, either two gene inheritance or another gene may be responsible for hearing loss.
 
</p></abstract><kwd-group><kwd>Hearing Loss</kwd><kwd> GJB2</kwd><kwd> Mazandaran</kwd><kwd> Hereditary Deafness</kwd><kwd> Nonsyndromic</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Deafness is one of the most common diseases in the world which is caused by hereditary or environmental factors or a combination of both [<xref ref-type="bibr" rid="scirp.104640-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref2">2</xref>] . Congenital deafness has a prevalence of 1.3 per 1000 population and in 70% of cases is not associated with other clinical symptoms [<xref ref-type="bibr" rid="scirp.104640-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref6">6</xref>] . Between 75% - 80% cases of non-syndromic deafness are inherited in an autosomal recessive pattern. Generally the frequency of hearing loss is reported 1 in 1000 live births in US and developed countries. The prevalence of deafness in Iran is higher due to the high rate of consanguineous marriages, approximately 3 per 1000 [<xref ref-type="bibr" rid="scirp.104640-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref8">8</xref>] . This disorder is extremely heterogeneous and more than 150 genes are identified causing deafness to date. So far, 121 genes responsible for non-syndromic deafness have been identified, of wich76 genes have autosomal recessive inheritance, others have autosomal dominant (54 genes) and X-linked (5 genes) inheritance (http://hereditaryhearingloss.org).</p><p>GJB2 gene, located at 13q12 and encodes Gap Junction beta2 protein, also known as connexin 26 protein and is necessary for cells to communicate with each other. This protein is localized in the cochlea and plays a role in k+ recycling pathway during auditory transduction [<xref ref-type="bibr" rid="scirp.104640-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref10">10</xref>] . Different types of mutation in GJB2 gene such as Missense, Nonsense and frameshift are the most common cause of non-syndromic deafness with autosomal recessive inheritance pattern. Although some mutations in this gene have been reported to be associated with autosomal dominant inheritance pattern [<xref ref-type="bibr" rid="scirp.104640-ref11">11</xref>] . So far, more than 300 pathogenic mutations have been reported for GJB2 gene that is associated with autosomal recessive non-syndromic deafness (http://databases.lovd.nl/shared/genes/GJB2). The most frequent mutations in this gene is c.35delG that occurs due to a G deletion in a sequence of 6 guanines from position 30 - 35 coding are and cause a frameshift and premature stop codon [<xref ref-type="bibr" rid="scirp.104640-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref14">14</xref>] .</p><p>The type and prevalence of mutations vary in different populations. The frequency of GJB2 mutations is reported from different provinces in Iran. It is generally as high as 22% to 38% in West Azarbaijan and East Azarbaijan province, Gilan and Golestan in the north and northwest provinces, to the average level of 16% in central provinces like Qom, Kerman, Isfahan, Yazd, Lorestan and as low as 4% to 0% in South Provinces like Sistan and Baluchestan [<xref ref-type="bibr" rid="scirp.104640-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref15">15</xref>] . In general, it is estimated about 16% prevalence for GJB2 related hearing loss in Iran [<xref ref-type="bibr" rid="scirp.104640-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref15">15</xref>] . Consanguineous marriage increases the frequency of homozygousity. It is estimated that 38% of the marriage is consanguineous and approximately 70% of cases are first cousins [<xref ref-type="bibr" rid="scirp.104640-ref16">16</xref>] . Also about 30,000 to 40,000 children are born every year with congenital disorders such as deafness [<xref ref-type="bibr" rid="scirp.104640-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref18">18</xref>] .</p><p>Deaf persons often require different kinds of medical care, specialized education and social services, reduced work productivity which leads extra cost to the society. Although GJB2 mutations are highly frequent in Northern provinces in Iran (Golestan, Mazandaran and Gilan), there are very few previous reports about GJB2 gene mutation frequency from Mazandaran province. The aim of this study was to investigate the frequency of GJB2 mutations in Mazandaran province, which could be useful for genetic counseling and prenatal diagnosis.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Subject</title><p>This prospective study was recruited 262 patients from 204 families with hearing loss from Mazandaran province, north of Iran who referred to Novin genetic diagnostic laboratory and counseling center, during the 11-year period, 2009-2020). After genetic counseling, family who was suspected to the hereditary form of hearing loss was included in this study. Any hearing loss with environmental cause was excluded from this study. All ethical issues, including confidentiality and informed consent were included in this study. All subjects were informed and were approved by the ethics committee of Mazandaran University of Medical Sciences.</p></sec><sec id="s2_2"><title>2.2. DNA Extraction and PCR Amplification</title><p>A total of 5 to 10 ml of peripheral blood was collected in a EDTA container tube from each person, then genomic DNA was extracted according to established protocols [<xref ref-type="bibr" rid="scirp.104640-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref20">20</xref>] . The quality and quantity of DNA samples were measured by Nanodrop spectrophotometer (Thermo Sci., Newington, NH). Two appropriate pairs of primers (<xref ref-type="table" rid="table1">Table 1</xref>) were applied (Macrogene, South chorea) to amplify exon 1 and exon 2 of GJB2 gene using polymerase chain reaction (PCR) followed by DNA sequencing method. A 850 bp and a 950 bp fragment was achieved by PCR amplification in a total volume of 25 μl respectively. Briefly, 2 μM of each primer (0.7 μl), 0.1 mM each dNTP (0.5 μl), 1&#215; PCR buffer (2.5 μl), 1.5 mM MgCl<sub>2</sub> (0.7 μl), 0.5 unit of Taq polymerase (0.2 μl) and 19.3 μl distillated water (Cinnagen, Iran) were used in each PCR tube. The following amplification conditions: initially denatured at 95˚C for 5 minute, followed by 35 cycles of denaturation at 95˚C for 1 minute, annealing at 60˚C for1minute and extension at 72˚C for 1 minute and a final extension at 72˚C for 5 min. Quality of PCR product was checked by electrophoresis, 5-μl of each PCR product on was run on 1% agarose gel.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Specific primers to amplify exon 1 and exon 2 of the GJB2 gene</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Exon 1: Forward</th><th align="center" valign="middle" >5'-GTGCGGTTAAAAGGCGCCAC-3'</th></tr></thead><tr><td align="center" valign="middle" >Exon 1: Reverse</td><td align="center" valign="middle" >5'-GGTGCCATCGCGTCCACTT-3'</td></tr><tr><td align="center" valign="middle" >Exon 2: Forward</td><td align="center" valign="middle" >5'-TGCTTGCTTACCCAGACTCA-3'</td></tr><tr><td align="center" valign="middle" >Exon 2: Reverse</td><td align="center" valign="middle" >5'-TTGTGGCATCTGGAGTTTCA-3'</td></tr></tbody></table></table-wrap></sec><sec id="s2_3"><title>2.3. DNA Sequencing and Genotype Analysis</title><p>Samples were subjected to further investigations using Sanger sequencing 3130XL Genetic Analyzers (ABI applied Biosystem, USA) for all individuals as a part of the diagnostic genetic laboratory services. In brief, specific primers were used to amplify entire exonic as well as 5' and 3' flanking intronic regions of the exon1 and exon2 of GJB2 gene, followed by DNA sequencing to find any variations or short deletion/insertions as described previously. Sequence analysis was performed using reference sequences from GenBank database. Gene Runner software (http://www.generunner.com) was used to align patient’s gene sequence, and Ref. sequence along with manual check of chromatogram from patient’s DNA sequence using FinchTV chromatogram viewer software (Geospiza) also was applied [<xref ref-type="bibr" rid="scirp.104640-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref20">20</xref>] .</p></sec><sec id="s2_4"><title>2.4. Statistical Analysis</title><p>Statistical analysis was performed using descriptive statistics. Allelic and genotype frequencies of the study variants were reported using basic descriptive statistics.</p></sec></sec><sec id="s3"><title>3. Results</title><p>262 patients from 204 families with hearing loss, including 154 severe were screened for GJB2 gene. 79 individuals (30.15%) showed mutations in GJB2 gene, which 72 individuals (27.48%) had two mutations with autosomal recessive inheritance and 7 individuals (2.67%) showed one mutation with autosomal dominant inheritance in GJB2 gene (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Also 161 (61.45%) individuals showed no mutations in GJB2 gene. From 262 patients, 22 (8.39%) individuals showed only one recessive mutation in GJB2 gene and were carrier (<xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Carrier frequency for GJB2 allele variant in 183 deaf individuals in whom GJB2 related hearing loss could not be identified (n = 22)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Genotype</th><th align="center" valign="middle" >Codon change</th><th align="center" valign="middle" >Total case</th><th align="center" valign="middle" >Frequency (%)</th></tr></thead><tr><td align="center" valign="middle" >IVSI + 1G &gt; A/_</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >36</td></tr><tr><td align="center" valign="middle" >c.35delG/_</td><td align="center" valign="middle" >Gly12Val fs/_</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >31.8</td></tr><tr><td align="center" valign="middle" >c.380G &gt; A/_</td><td align="center" valign="middle" >Arg127His/_</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >13.6</td></tr><tr><td align="center" valign="middle" >c.95G &gt; A/_</td><td align="center" valign="middle" >Arg32His/_</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >c.478G &gt; A/_</td><td align="center" valign="middle" >Gly160Ser/_</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.5</td></tr><tr><td align="center" valign="middle" >c.138T &gt; G/_</td><td align="center" valign="middle" >Asp46Glu/_</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >4.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >22</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>35delG and IVSI-1 + 1G &gt; A were the most common mutations among patients in this study, respectively (<xref ref-type="table" rid="table1">Table 1</xref>). Also 4 mutations, including c.35delG (Gly12Valfs), IVSI-1 + 1G &gt; A, c.95G &gt; A (Arg32His) and c.224 G &gt; A (Arg75Gln) comprises 91.27% of all mutations among 173 mutant alleles in this study (<xref ref-type="table" rid="table3">Table 3</xref>). Codon 75 mutation (Arg75Gln) with autosomal dominant inheritance was seen in 7 cases from 3 families. Two polymorphisms (c.457G &gt; A and c.79G &gt; A) also were seen in this study with total frequency of 2.28%.</p><p>Genotype composition and genotype frequency of the patients are shown in <xref ref-type="table" rid="table4">Table 4</xref>. As it is expected, homozygous patients for three most frequent recessive mutations are more common among patients (<xref ref-type="table" rid="table3">Table 3</xref>). In 126 (48.09%) individuals, parents had consanguineous marriage. Three family pedigrees, one with autosomal dominant and two with autosomal recessive inheritance are shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p></sec><sec id="s4"><title>4. Discussion</title><p>The GJB2 gene related hearing loss in Iran varies between 35% to zero, shows a decreasing trend from north to south of the country with average about 16% according to the previous studies [<xref ref-type="bibr" rid="scirp.104640-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref24">24</xref>] . GJB2 gene-related hearing loss is generally higher in the North and is reported as high as 38% in some area in Gilan and Golestan provinces [<xref ref-type="bibr" rid="scirp.104640-ref15">15</xref>] . A previous study performed by Najmabadi et al. in 664 autosomal recessive non-syndromic hearing loss families from different geographic areas including 47 probands from North of Iran reported 38.3% frequency of GJB2 gene related hearing loss [<xref ref-type="bibr" rid="scirp.104640-ref25">25</xref>] . Also in another study by Bazazzadegan et al., which was conducted on 2322 families from 31 provinces of Iran during twelve years, the highest prevalence of GJB2 gene mutations was belongs to the north of Iran, with 33% in Mazani and Gilaki ethnic groups [<xref ref-type="bibr" rid="scirp.104640-ref26">26</xref>] . In this study that 262 deaf individuals from Mazandaran province were recruited, the results showed that the frequency of GJB2 mutations related non-syndromic hearing loss was 30.15% respectively. 4 mutations, including c.35delG, IVSI-1G &gt; A, c.95G &gt; A and c.224G &gt; A accounted for about 70% of all detected mutations.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Number and prevalence of different mutations found in GJB2 gene in affected individuals with hearing loss (n = 262)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Mutation</th><th align="center" valign="middle" >Codon change</th><th align="center" valign="middle" >Number of alleles</th><th align="center" valign="middle" >Frequency (%)</th></tr></thead><tr><td align="center" valign="middle" >c.35delG</td><td align="center" valign="middle" >Gly12Val fs</td><td align="center" valign="middle" >108</td><td align="center" valign="middle" >62.42</td></tr><tr><td align="center" valign="middle" >IVS1 + 1G &gt; A</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >14.45</td></tr><tr><td align="center" valign="middle" >c.95G &gt; A</td><td align="center" valign="middle" >Arg32His</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >10.4</td></tr><tr><td align="center" valign="middle" >c.224G &gt; A</td><td align="center" valign="middle" >Arg75Gln</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >c.551G &gt; C</td><td align="center" valign="middle" >Arg184Pro</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2.8</td></tr><tr><td align="center" valign="middle" >c.380G &gt; A</td><td align="center" valign="middle" >Arg127His</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.73</td></tr><tr><td align="center" valign="middle" >c.478G &gt; A</td><td align="center" valign="middle" >Gly160Ser</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.15</td></tr><tr><td align="center" valign="middle" >c.138T &gt; G</td><td align="center" valign="middle" >Asp46Glu</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.57</td></tr><tr><td align="center" valign="middle" >c.274G &gt; T</td><td align="center" valign="middle" >Ala92Ser</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.57</td></tr><tr><td align="center" valign="middle" >c.229T &gt; C</td><td align="center" valign="middle" >Trp77Arg</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.57</td></tr><tr><td align="center" valign="middle" >c.428G &gt; A</td><td align="center" valign="middle" >Arg143Gln</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.57</td></tr><tr><td align="center" valign="middle" >c.71G &gt; A</td><td align="center" valign="middle" >Trp24Ter</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.57</td></tr><tr><td align="center" valign="middle" >c.408C &gt; A</td><td align="center" valign="middle" >Tyr136Ser</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.57</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Total</td><td align="center" valign="middle" >173</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> List of GJB2 genotype with biallelic recessive pathogenic mutation in 72 deaf individuals</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Genotype</th><th align="center" valign="middle" >Codon change</th><th align="center" valign="middle" >Total case</th><th align="center" valign="middle" >Frequency (%)</th></tr></thead><tr><td align="center" valign="middle" >c.35delG/c.35delG</td><td align="center" valign="middle" >Gly12Val fs/Gly12Val fs</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >16.41</td></tr><tr><td align="center" valign="middle" >c.95G &gt; A/c.95G &gt; A</td><td align="center" valign="middle" >Arg32His/Arg32His</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >2.67</td></tr><tr><td align="center" valign="middle" >IVSI + 1G &gt; A/IVSI + 1G &gt; A</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.76</td></tr><tr><td align="center" valign="middle" >c.551G &gt; C/c.551G &gt; C</td><td align="center" valign="middle" >Arg184Pro/Arg184Pro</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >c.35delG/ IVSI + 1G &gt; A</td><td align="center" valign="middle" >Gly12Val fs/IVSI + 1G &gt; A</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >3.43</td></tr><tr><td align="center" valign="middle" >c.35delG/c.551G &gt; C</td><td align="center" valign="middle" >Gly12Val fs/Arg184Pro</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.76</td></tr><tr><td align="center" valign="middle" >c.35delG/c.229T &gt; C</td><td align="center" valign="middle" >Gly12Val fs/Trp77Arg</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >c.35delG/c.95G &gt; A</td><td align="center" valign="middle" >Gly12Val fs/Arg32His</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >c.478G &gt; A/IVSI + 1G &gt; A</td><td align="center" valign="middle" >Gly160Ser/IVSI + 1G &gt; A</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >IVSI + 1G &gt; A/c.408C &gt; A</td><td align="center" valign="middle" >IVSI + 1G &gt; A/Tyr136Ser</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >c.95G &gt; A/IVSI + 1G &gt; A</td><td align="center" valign="middle" >Arg32His/IVSI + 1G &gt; A</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >c.551G &gt; C/IVSI + 1G &gt; A</td><td align="center" valign="middle" >Arg184Pro/IVSI + 1G &gt; A</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >c.35delG/c.428G &gt; A</td><td align="center" valign="middle" >Gly12Val fs/Arg143Gln</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >c.35delG/c.71G &gt; A</td><td align="center" valign="middle" >Gly12Val fs/Trp24Ter</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.38</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >72</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>c.35delG was the most common GJB2 mutation accounted for 108 out of 226 (47.78%) mutated alleles in this study. c.35delG first was reported by Zlante et al. 1997 [<xref ref-type="bibr" rid="scirp.104640-ref27">27</xref>] . In Caucasians, this mutation is responsible for 20% of all hereditary hearing loss [<xref ref-type="bibr" rid="scirp.104640-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref30">30</xref>] . Frequency of c.35delG carrier is reported 1.26 % in Northern Europe and 1.96% in Southern Europe [<xref ref-type="bibr" rid="scirp.104640-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref32">32</xref>] . Also its’ frequency is reported 1.52%, 0.64%, 1% and 0.64% among American, Asian, Oceanic, and African populations respectively [<xref ref-type="bibr" rid="scirp.104640-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref32">32</xref>] . In Azarbayjan population, Iran neighbor, frequency of c.35delG mutation has been estimated 18% [<xref ref-type="bibr" rid="scirp.104640-ref33">33</xref>] and in Turkish population, it is reported 5% - 53% respectively [<xref ref-type="bibr" rid="scirp.104640-ref34">34</xref>] . In Iran, c.35delG also is the most frequent mutation among deaf individuals [<xref ref-type="bibr" rid="scirp.104640-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref36">36</xref>] . The c.35delG frequency is more in North and Northwest comparing to south of the country [<xref ref-type="bibr" rid="scirp.104640-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref37">37</xref>] . In one study on 298 familial and 592 sporadic subjects from ten provinces, c.35delG was the most prevalent mutation accounted for 193 out of 259 (74.5%) of the GJB2 mutated alleles [<xref ref-type="bibr" rid="scirp.104640-ref35">35</xref>] . Also, c.35delG frequency was reported 27%, 9.1% and 18% for Gilan, Golestan and East Azarbayjan provinces in the north and 0% in Sistan and Baluchestan province in the south respectively [<xref ref-type="bibr" rid="scirp.104640-ref35">35</xref>] . In this study, from 524 alleles tested, 108 (20.64%) had c.35delG mutation, which is similar to the finding of previous studies.</p><p>IVSI + 1G &gt; A is a splice site mutation in non-coding exon 1 of the GJB2 gene that was reported by Denoyelle et al. [<xref ref-type="bibr" rid="scirp.104640-ref38">38</xref>] . It has been found in several populations and frequent among Czech, Hungarian, Yakut and Turkish [<xref ref-type="bibr" rid="scirp.104640-ref39">39</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref40">40</xref>] . This mutation is the third most common GJB2 mutation in Czech [<xref ref-type="bibr" rid="scirp.104640-ref39">39</xref>] and also it is reported 4.33% with total allele frequency in Turkish population [<xref ref-type="bibr" rid="scirp.104640-ref41">41</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref42">42</xref>] . In Iran, the IVS1 + 1G &gt; A is one of five most prevalent GJB2 mutations with frequency about 4.5% [<xref ref-type="bibr" rid="scirp.104640-ref23">23</xref>] , with as high as 9.1%in Kurdish ethnic group [<xref ref-type="bibr" rid="scirp.104640-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref43">43</xref>] . Results from this study also showed IVS1 + 1G &gt; A as a second most common mutation in Mazandaran with the frequency of 14.45% (25 of 226) of the GJB2 mutated chromosomes.</p><p>c.95G &gt; A (Arg32His) is a third most frequent mutation accounted for 10.4% (18 out of 173) mutated chromosomes in this study. Previous studies reported in one out of 70 consanguineous families from Isfahan, estimated 2.5% frequency in central area of Iran [<xref ref-type="bibr" rid="scirp.104640-ref44">44</xref>] , 5 out of 1328 total allele tested (0.37%) in other study [<xref ref-type="bibr" rid="scirp.104640-ref25">25</xref>] and also 2 out of 131 (1.52%) in an unrelated nonsyndromic hearing loss samples from central part of Iran [<xref ref-type="bibr" rid="scirp.104640-ref1">1</xref>] . Results achieved from this study revealed slightly higher frequency of 3.43% (18 out of 524 alleles) from total chromosome studied.</p><p>c.224G &gt; A (Arg75Gln) cause autosomal dominant hearing loss [<xref ref-type="bibr" rid="scirp.104640-ref26">26</xref>] . In this study, 7 individuals from 3 families (7 out of 173 affected alleles) (4%) were seen with this mutation, with non-syndromic hearing loss (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>). To date, 54 dominant mutations in GJB2 gene have been identified worldwide (http://hereditaryhearingloss.org), of which about two-third can cause syndromic hearing loss and remaining causes autosomal dominant non-syndromic hearing loss [<xref ref-type="bibr" rid="scirp.104640-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref45">45</xref>] .</p><p>For those 22 patients who showed only one mutation in GJB2 gene, a digenic inheritance could be involved or another gene rather than GJB2 may be responsible for hearing loss. Because hearing loss is heterogeneous, so it is a good candidate for digenic inheritance [<xref ref-type="bibr" rid="scirp.104640-ref46">46</xref>] . Several examples of digenic inheritance have been reported for hearing loss, such as PCDH15 and CDH23, SLC26A4 and FOX1, SLC26A4 and KCNJ10, MYO7A and PCDH15, PCDH and USH1G [<xref ref-type="bibr" rid="scirp.104640-ref47">47</xref>] . For GJB2 gene, different digenic inheritance including GJB2 and GJB6, GJB2 and GJB3, GJB2 and MIFT has been reported before [<xref ref-type="bibr" rid="scirp.104640-ref48">48</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref49">49</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref50">50</xref>] . More investigation is needed to find other mechanisms that are involved.</p><p>c.457G &gt; A, (Val153Ile) substitution was seen 12 out of 262 (4.58%) deaf individuals. This change has been reported as a pathogenic allele with recessive inheritance [<xref ref-type="bibr" rid="scirp.104640-ref51">51</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref52">52</xref>] as well as a polymorphism [<xref ref-type="bibr" rid="scirp.104640-ref53">53</xref>] [<xref ref-type="bibr" rid="scirp.104640-ref54">54</xref>] . In one study, Mes et al. demonstrate that the c.457G &gt; A change could be pathogenic as they showed that mutated protein was unable to form functional channels in Xenopus oocyte expression system [<xref ref-type="bibr" rid="scirp.104640-ref55">55</xref>] . In another review study, Mahdieh et al. revealed c.457G &gt; A with a frequency of 93 out of 148 (62.84%) among polymorphic alleles and 2.4% in total reported alleles and concluded it as a polymorphism [<xref ref-type="bibr" rid="scirp.104640-ref22">22</xref>] . Similarly, Bazzazzadegan et al. found 64% (89 out of 4644 alleles) in 2322 nonsyndromic hearing loss probands from different ethnics in Iran and conclude this change is a polymorphism [<xref ref-type="bibr" rid="scirp.104640-ref23">23</xref>] . The pathogenic effect of this amino acid substitution is controversial and remains to be confirmed.</p><p>Finally, our finding showed that 79 individuals (30.15%) showed mutations in GJB2 gene in this study, also in 161 individuals (61.45%), GJB2 gene was not involved in their hearing problem. This study also showed dominant inheritance of GJB2 gene in this area. Along with mutation detection, also we found that about 48% of patients resulted from consanguineous marriage. There was also some limitation in this study. The audiometry test result from all patients was not available, so the exact phenotype-genotype correlation study was not possible in this investigation. As deafness is a heterogeneous disease, in cases that GJB2 gene is not responsible for the disease, another gene may involve, so analysis of all other known genes for hearing loss needs to be analyzed using next generation sequencing system.</p></sec><sec id="s5"><title>Acknowledgements</title><p>We would like to thank those patients who participate in this study and also the Novin Genetic Laboratory members who helped us during this study.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Hosseini, E., Mousavi, S.S., Khoshaein, A., Daneshpour, F., Vandchali, M.R. and Hashemi-Soteh, S.M.B. (2020) GJB2 Gene Related Nonsyndromic Hearing Loss in Mazandaran Province, North of Iran. Open Journal of Genetics, 10, 51-63. https://doi.org/10.4236/ojgen.2020.103005</p></sec></body><back><ref-list><title>References</title><ref id="scirp.104640-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Naddafnia, H., Noormohammadi, Z., Irani, S. and Salahshoorifar, I. (2019) Frequency of GJB2 Mutations, GJB6-D13S1830 and GJB6-D13S1854 Deletions among Patients with Non-Syndromic Hearing Loss from the Central Region of Iran. Molecular Genetics &amp; Genomic Medicine, 7, e00780. https://doi.org/10.1002/mgg3.780</mixed-citation></ref><ref id="scirp.104640-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Nance, W.E. (2003) The Genetics of Deafness. Mental Retardation and Developmental Disabilities Research Reviews, 9, 109-119. https://doi.org/10.1002/mrdd.10067</mixed-citation></ref><ref id="scirp.104640-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Adadey, S.M., Manyisa, N., Mnika, K., De Kock, C., Nembaware, V., et al. (2019) GJB2 and GJB6 Mutations in Non-Syndromic Childhood Hearing Impairment in Ghana. Frontiers in Genetics, 10, 841. https://doi.org/10.3389/fgene.2019.00841</mixed-citation></ref><ref id="scirp.104640-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Esmaeili, M., Bonyadi, M. and Nejadkazem, M. (2007) Common Mutation Analysis of GJB2 and GJB6 Genes in Affected Families with Autosomal Recessive Non-Syndromic Hearing Loss from Iran: Simultaneous Detection of Two Common Mutations (35delG/del (GJB6-D13S1830)) in the DFNB1-Related Deafness. International Journal of Pediatric Otorhinolaryngology, 71, 869-873. https://doi.org/10.1016/j.ijporl.2007.02.007</mixed-citation></ref><ref id="scirp.104640-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Morton, N. (1991) Genetic Epidemiology of Hearing Impairment. Annals of the New York Academy of Sciences, 630, 16-31. https://doi.org/10.1111/j.1749-6632.1991.tb19572.x</mixed-citation></ref><ref id="scirp.104640-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Bademci, G., Cengiz, F., Foster II, J., Duman, D., Sennaroglu, L., et al. (2016) Variations in Multiple Syndromic Deafness Genes Mimic Non-Syndromic Hearing Loss. Scientific Reports, 6, Article No. 31622. https://doi.org/10.1038/srep31622</mixed-citation></ref><ref id="scirp.104640-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Beheshtian, M., Babanejad, M., Azaiez, H., Bazazzadegan, N., Kolbe, D., et al. (2016) Heterogeneity of Hereditary Hearing Loss in Iran: A Comprehensive Review. Archives of Iranian Medicine, 19, 720.</mixed-citation></ref><ref id="scirp.104640-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Khalil, A., Karroum, S.B., Barake, R., Dunya, G., Abou-Rizk, S., et al. (2020) Post-Lingual Non-Syndromic Hearing Loss Phenotype: A Polygenic Case with 2 Biallelic Mutations in MYO15A and MITF. BMC Medical Genetics, 21, Article No. 1. https://doi.org/10.1186/s12881-019-0942-4</mixed-citation></ref><ref id="scirp.104640-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Marziano, N.K., Casalotti, S.O., Portelli, A.E., Becker, D.L. and Forge, A. (2003) Mutations in the Gene for Connexin 26 (GJB2) That Cause Hearing Loss Have a Dominant Negative Effect on Connexin 30. Human Molecular Genetics, 12, 805-812. https://doi.org/10.1093/hmg/ddg076</mixed-citation></ref><ref id="scirp.104640-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Snoeckx, R.L., Huygen, P.L., Feldmann, D., Marlin, S., Denoyelle, F., et al. (2005) GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study. The American Journal of Human Genetics, 77, 945-957. https://doi.org/10.1086/497996</mixed-citation></ref><ref id="scirp.104640-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Zheng, J., Ying, Z., Cai, Z., Sun, D., He, Z., Cao, Y., et al. (2015) GJB2 Mutation Spectrum and Genotype-Phenotype Correlation in 1067 Han Chinese Subjects with Non-Syndromic Hearing Loss. PloS One, 10, e0128691. https://doi.org/10.1371/journal.pone.0128691</mixed-citation></ref><ref id="scirp.104640-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Cifuentes Ovalle, L., Arancibia, M., Torrente Avenda&amp;#241o, M., Acu&amp;#241a, M., Farfán Reyes, C., et al. (2013) Prevalence of the 35delG Mutation in the GJB2 Gene in Two Samples of Non-Syndromic Deaf Subjects from Chile. Biological Research, 46, No. 3. https://doi.org/10.4067/S0716-97602013000300003</mixed-citation></ref><ref id="scirp.104640-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Kaheel, H., Bre&amp;#223, A., Hassan, M.A., Shah, A.A., Amin, M., et al. (2017) Frequency of c. 35delG Mutation in GJB2 Gene (Connexin 26) in Syrian Patients with Nonsyndromic Hearing Impairment. Genetics Research International, 2017, Article ID: 5836525. https://doi.org/10.1155/2017/5836525</mixed-citation></ref><ref id="scirp.104640-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Azadegan-Dehkordi, F., Bahrami, T., Shirzad, M., Karbasi, G., Yazdanpanahi, N., et al. (2019) Mutations in GJB2 as Major Causes of Autosomal Recessive Non-Syndromic Hearing Loss: First Report of c. 299-300delAT Mutation in Kurdish Population of Iran. Journal of Audiology &amp; Otology, 23, 20-26. https://doi.org/10.7874/jao.2018.00185</mixed-citation></ref><ref id="scirp.104640-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Koohiyan, M., Koohian, F. and Azadegan-Dehkordi, F. (2020) GJB2-Related Hearing Loss in Central Iran: Review of the Spectrum and Frequency of Gene Mutations. Annals of Human Genetics, 84, 107-113. https://doi.org/10.1111/ahg.12354</mixed-citation></ref><ref id="scirp.104640-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Nouri, N., Nouri, N., Tirgar, S., Soleimani, E., Yazdani, V., et al. (2017) Consanguineous Marriages in the Genetic Counseling Centers of Isfahan and the Ethical Issues of Clinical Consultations. The Journal of Medical Ethics and History of Medicine, 10, 12.</mixed-citation></ref><ref id="scirp.104640-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hashemi-Soteh, M.B., Nejad, A.V., Ataei, G., Tafazoli, A., Ghasemi, D., et al. (2019) Knowledge and Attitude toward Genetic Diseases and Genetic Tests among Pre-Marriage Individuals: A Cross-Sectional Study in Northern Iran. International Journal of Reproductive BioMedicine, 17, 543.</mixed-citation></ref><ref id="scirp.104640-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Rafiee, L. and Saadat, M. (2011) Prevalence of Consanguineous Marriages among Iranian Georgians. Journal of Biosocial Science, 43, 47-50. https://doi.org/10.1017/S0021932010000295</mixed-citation></ref><ref id="scirp.104640-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Hashemi-Soteh, S.M.B., Sarzare, F., Merat, F., Salehifar, E. and Shiran, M.-R. (2011) Frequencies of Three CYP2D6 Nonfunctional Alleles (CYP2D6*3, *4, and *6) within an Iranian Population (Mazandaran). Genetic Testing and Molecular Biomarkers, 15, 821-825. https://doi.org/10.1089/gtmb.2011.0033</mixed-citation></ref><ref id="scirp.104640-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Hashemi-Soteh, S.M.B., Shahabi-Majd, N., Gholizadeh, A.-R. and Shiran, M.-R. (2012) Allele and Genotype Frequencies of CYP2C9 within an Iranian Population (Mazandaran). Genetic Testing and Molecular Biomarkers, 16, 817-821. https://doi.org/10.1089/gtmb.2011.0301</mixed-citation></ref><ref id="scirp.104640-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Najmabadi, H., Cucci, R.A., Sahebjam, S., Kouchakian, N., Farhadi, M., et al. (2002) GJB2 Mutations in Iranians with Autosomal Recessive Non-Syndromic Sensorineural Hearing Loss. Human Mutation, 19, 572-572. https://doi.org/10.1002/humu.9033</mixed-citation></ref><ref id="scirp.104640-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Mahdieh, N., Rabbani, B., Wiley, S., Akbari, M.T. and Zeinali, S. (2010) Genetic Causes of Nonsyndromic Hearing Loss in Iran in Comparison with Other Populations. Journal of Human Genetics, 55, 639-648. https://doi.org/10.1038/jhg.2010.96</mixed-citation></ref><ref id="scirp.104640-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Bazazzadegan, N., Nikzat, N., Fattahi, Z., Nishimura, C., Meyer, N., et al. (2012) The Spectrum of GJB2 Mutations in the Iranian Population with Non-Syndromic Hearing Loss—A Twelve Year Study. International Journal of Pediatric Otorhinolaryngology, 76, 1164-1174. https://doi.org/10.1016/j.ijporl.2012.04.026</mixed-citation></ref><ref id="scirp.104640-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Zeinali, S., Davoudi-Dehaghani, E., Azadmehr, S., DabbaghBagheri, S., Bagherian, H., et al. (2015) GJB2 c.&amp;#45 23 + 1G &gt; A Mutation Is Second Most Common Mutation among Iranian Individuals with Autosomal Recessive Hearing Loss. European Archives of Oto-Rhino-Laryngology, 272, 2255-2259. https://doi.org/10.1007/s00405-014-3171-7</mixed-citation></ref><ref id="scirp.104640-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Najmabadi, H., Nishimura, C., Kahrizi, K., Riazalhosseini, Y., Malekpour, M., et al. (2005) GJB2 Mutations: Passage through Iran. American Journal of Medical Genetics Part A, 133, 132-137. https://doi.org/10.1002/ajmg.a.30576</mixed-citation></ref><ref id="scirp.104640-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Bazazzadegan, N., Sheffield, A.M., Sobhani, M., Kahrizi, K., Meyer, N.C., et al. (2011) Two Iranian Families with a Novel Mutation in GJB2 Causing Autosomal Dominant Nonsyndromic Hearing Loss. American Journal of Medical Genetics Part A, 155, 1202-1211. https://doi.org/10.1002/ajmg.a.33209</mixed-citation></ref><ref id="scirp.104640-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Zelante, L., Gasparini, P., Estivill, X., Melchionda, S., D’Agruma, L., et al. (1997) Connexin26 Mutations Associated with the Most Common form of Non-Syndromic Neurosensory Autosomal Recessive Deafness (DFNB1) in Mediterraneans. Human Molecular Genetics, 6, 1605-1609. https://doi.org/10.1093/hmg/6.9.1605</mixed-citation></ref><ref id="scirp.104640-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Kelley, P., Harris, D., Comer, B., Askew, J., Fowler, T., et al. (1998) Novel Mutations in the Connexin 26 Gene (GJB2) That Cause Autosomal Recessive (DFNB1) Hearing Loss. The American Journal of Human Genetics, 62, 792-799. https://doi.org/10.1086/301807</mixed-citation></ref><ref id="scirp.104640-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Toumpas, C.J., Clark, J., Harris, A., Beswick, R. and Nourse, C.B. (2015) Congenital Cytomegalovirus Infection Is a Significant Cause of Moderate to Profound Sensorineural Hearing Loss in Queensland Children. Journal of Paediatrics and Child Health, 51, 541-544. https://doi.org/10.1111/jpc.12776</mixed-citation></ref><ref id="scirp.104640-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Petersen, M. and Willems, P. (2006) Non-Syndromic, Autosomal-Recessive Deafness. Clinical Genetics, 69, 371-392. https://doi.org/10.1111/j.1399-0004.2006.00613.x</mixed-citation></ref><ref id="scirp.104640-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Prasad, S., Cucci, R., Green, G. and Smith, R. (2000) Genetic Testing for Hereditary Hearing Loss: Connexin 26 (GJB2) Allele Variants and Two Novel Deafness-Causing Mutations (R32C and 645-648delTAGA). Human Mutation, 16, 502-508. https://doi.org/10.1002/1098-1004(200012)16:6&lt;502::AID-HUMU7&gt;3.0.CO;2-4</mixed-citation></ref><ref id="scirp.104640-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Mahdieh, N. and Rabbani, B. (2009) Statistical Study of 35delG Mutation of GJB2 Gene: A Meta-Analysis of Carrier Frequency. International Journal of Audiology, 48, 363-370. https://doi.org/10.1080/14992020802607449</mixed-citation></ref><ref id="scirp.104640-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Bar&amp;#305&amp;#351, I., K&amp;#305l&amp;#305n&amp;#231, M. and Tolun, A. (2001) Frequency of the 35delG Mutation in the Connexin 26 Gene in Turkish Hearing-Impaired Patients. Clinical Genetics, 60, 452-455. https://doi.org/10.1034/j.1399-0004.2001.600608.x</mixed-citation></ref><ref id="scirp.104640-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Tekin, M., Duman, T., Bo&amp;#287o&amp;#231lu, G., &amp;#304ncesulu, A., &amp;#199omak, E., et al. (2003) Spectrum of GJB2 Mutations in Turkey Comprises Both Caucasian and Oriental Variants: Roles of Parental Consanguinity and Assortative Mating. Human Mutation, 21, 552-553. https://doi.org/10.1002/humu.9137</mixed-citation></ref><ref id="scirp.104640-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Chaleshtori, M.H., Farhud, D., Taylor, R., Hadavi, V., Patton, M., et al. (2002) Deafness-Associated Connexin 26 Gene (GJB2) Mutations in Iranian Population. Iranian Journal of Public Health, 31, 75-79.</mixed-citation></ref><ref id="scirp.104640-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Sadeghi, A., Sanati, M.H., Alasti, F., Hashemzadeh Chaleshtori, M. and Ataei, M. (2005) Mutation Analysis of Connexin 26 Gene and Del (GJB6-D13S1830) in Patients with Hereditary Deafness from Two Provinces in Iran. Iranian Journal of Biotechnology, 3, 255-258.</mixed-citation></ref><ref id="scirp.104640-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Mehri-Ghahfarrokhi, A., Hashemzadeh-Chaleshtori, M., Shojaeian, A. and Mahmoudian Sani, M.R. (2017) Studying Gap Junction Beta 2-Related Deafness in Iranian Population. Otorinolaringologia, 67, 89-95.</mixed-citation></ref><ref id="scirp.104640-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Denoyelle, F., Marlin, S., Weil, D., Moatti, L., Chauvin, P., et al. (1999) Clinical Features of the Prevalent form of Childhood Deafness, DFNB1, Due to a Connexin-26 Gene Defect: Implications for Genetic Counselling. The Lancet, 353, 1298-1303. https://doi.org/10.1016/S0140-6736(98)11071-1</mixed-citation></ref><ref id="scirp.104640-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Seeman, P. and Sakmaryova, I. (2006) High prevalence of the IVS 1 + 1 G to A/GJB2 Mutation among Czech Hearing Impaired Patients with Monoallelic Mutation in the Coding Region of GJB2. Clinical Genetics, 69, 410-413. https://doi.org/10.1111/j.1399-0004.2006.00602.x</mixed-citation></ref><ref id="scirp.104640-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Bonyadi, M.J., Fotouhi, N. and Esmaeili, M. (2014) Spectrum and Frequency of GJB2 Mutations Causing Deafness in the Northwest of Iran. International Journal of Pediatric Otorhinolaryngology, 78, 637-640. https://doi.org/10.1016/j.ijporl.2014.01.022</mixed-citation></ref><ref id="scirp.104640-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Sirmaci, A., Akcayoz-Duman, D. and Tekin, M. (2006) The c. IVS1 + 1G &gt; A Mutation in the GJB2 Gene Is Prevalent and Large Deletions Involving the GJB6 Gene Are Not Present in the Turkish Population. Journal of Genetics, 85, 213-216. https://doi.org/10.1007/BF02935334</mixed-citation></ref><ref id="scirp.104640-ref42"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Biyikli</surname><given-names> T.A. </given-names></name>,<etal>et al</etal>. (<year>2012</year>)<article-title>Prevalence of the IVS1 (+1) G &gt; A and 35delG Mutations in the GJB2 Gene of Turkish Patients with Nonsyndromic Hearing Loss</article-title><source> Turkish Journal of Biology</source><volume> 36</volume>,<fpage> 1</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.104640-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Asma, A., Ashwaq, A., Norzana, A., Atmadini, A.M., Ruszymah, B., et al. (2011) The Association between GJB2 Mutation and GJB6 Gene in Non Syndromic Hearing Loss School Children. Med J Malaysia, 66, 125.</mixed-citation></ref><ref id="scirp.104640-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Koohiyan, M., Hashemzadeh-Chaleshtori, M., Salehi, M., Abtahi, H., Reiisi, S., et al. (2018) GJB2 Mutations Causing Autosomal Recessive Non-Syndromic Hearing Loss (ARNSHL) in Two Iranian Populations: Report of Two Novel Variants. International Journal of Pediatric Otorhinolaryngology, 107, 121-126. https://doi.org/10.1016/j.ijporl.2018.01.012</mixed-citation></ref><ref id="scirp.104640-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Wang, H., Wu, K., Yu, L., Xie, L., Xiong, W., et al. (2017) A Novel Dominant GJB2 (DFNA3) Mutation in a Chinese Family. Scientific Reports, 7, Article No. 34425. https://doi.org/10.1038/srep34425</mixed-citation></ref><ref id="scirp.104640-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Oldak, M., Lechowicz, U., Pollak, A., Ozieblo, D. and Skarzynski, H. (2019) Overinterpretation of High Throughput Sequencing Data in Medical Genetics: First Evidence against TMPRSS3/GJB2 Digenic Inheritance of Hearing Loss. Journal of Translational Medicine, 17, Article No. 269. https://doi.org/10.1186/s12967-019-2018-9</mixed-citation></ref><ref id="scirp.104640-ref47"><label>47</label><mixed-citation publication-type="other" xlink:type="simple">Schrauwen, I., Chakchouk, I., Acharya, A., Liaqat, K., Irfanullah, et al. (2018) Novel Digenic Inheritance of PCDH15 and USH1G Underlies Profound Non-Syndromic Hearing Impairment. BMC Med Genet, 19, Article No. 122. https://doi.org/10.1186/s12881-018-0618-5</mixed-citation></ref><ref id="scirp.104640-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Liu, X.Z., Yuan, Y., Yan, D., Ding, E.H., Ouyang, X.M., et al. (2009) Digenic Inheritance of Non-Syndromic Deafness Caused by Mutations at the Gap Junction Proteins Cx26 and Cx31. Human Genetics, 125, 53-62. https://doi.org/10.1007/s00439-008-0602-9</mixed-citation></ref><ref id="scirp.104640-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Kim, S.Y., Kim, A.R., Kim, N.K., Lee, C., Kim, M.Y., et al. (2016) Unraveling of Enigmatic Hearing-Impaired GJB2 Single Heterozygotes by Massive Parallel Sequencing: DFNB1 or Not? Medicine (Baltimore), 95, e3029. https://doi.org/10.1097/MD.0000000000003029</mixed-citation></ref><ref id="scirp.104640-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Chen, K., Wu, X., Zong, L. and Jiang, H. (2018) GJB3/GJB6 Screening in GJB2 Carriers with Idiopathic Hearing Loss: Is It Necessary? Journal of Clinical Laboratory Analysis, 32, e22592. https://doi.org/10.1002/jcla.22592</mixed-citation></ref><ref id="scirp.104640-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Wu, B.-L., Lindeman, N., Lip, V., Adams, A., Amato, R.S., et al. (2002) Effectiveness of Sequencing Connexin 26 (GJB2) in Cases of Familial or Sporadic Childhood Deafness Referred for Molecular Diagnostic Testing. Genetics in Medicine, 4, 279-288. https://doi.org/10.1097/00125817-200207000-00006</mixed-citation></ref><ref id="scirp.104640-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Rickard, S., Kelsell, D.P., Sirimana, T., Rajput, K., MacArdle, B., et al. (2001) Recurrent Mutations in the Deafness Gene GJB2 (Connexin 26) in British Asian Families. Journal of Medical Genetics, 38, 530-533. https://doi.org/10.1136/jmg.38.8.530</mixed-citation></ref><ref id="scirp.104640-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Hashemzadeh Chaleshtori, M., Farhoud, D. and Patton, M. (2007) Familial and Sporadic GJB2-Related Deafness in Iran: Review of Gene Mutations. Iranian Journal of Public Health, 36, 1-14.</mixed-citation></ref><ref id="scirp.104640-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Marlin, S., Garabédian, E.-N., Roger, G., Moatti, L., Matha, N., et al. (2001) Connexin 26 Gene Mutations in Congenitally Deaf Children: Pitfalls for Genetic Counseling. Archives of Otolaryngology-Head &amp; Neck Surgery, 127, 927-933. https://doi.org/10.1001/archotol.127.8.927</mixed-citation></ref><ref id="scirp.104640-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Me&amp;#351e, G., Londin, E., Mui, R., Brink, P.R. and White, T.W. (2004) Altered Gating properties of Functional Cx26 Mutants Associated with Recessive Non-Syndromic Hearing Loss. Human Genetics, 115, 191-199. https://doi.org/10.1007/s00439-004-1142-6</mixed-citation></ref></ref-list></back></article>